![](/img/cover-not-exists.png)
2761 Phase II clinical trial of 6 mercaptopurine (6MP) and methotrexate in patients with BRCA defective tumours
Nicum, S., Boyle, L., Strauss, V., Gourley, C., Hall, M., Montes, A., Abraham, J., Clamp, A., Kennedy, R., Banerjee, S., Roberts, C.Volume:
51
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/s0959-8049(16)31527-1
Date:
September, 2015
File:
PDF, 59 KB
english, 2015